Toggle navigation
About
Abstract
Editorial Board
Subscription & Newsletter
Contact
Issues
This issue
21-3
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
21-3
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #85535
advertisement
Hui F
15
Showing records 1 to 15 |
Display all abstracts from
Hui F
90545
Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: A crossover randomized clinical trial
Hui F
Clinical and Experimental Ophthalmology
2020; 48: 903-914
90237
Short-Term Changes in the Photopic Negative Response Following Intraocular Pressure Lowering in Glaucoma
Tang J
Investigative Ophthalmology and Visual Science
2020; 61: 16
90545
Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: A crossover randomized clinical trial
Tang J
Clinical and Experimental Ophthalmology
2020; 48: 903-914
90237
Short-Term Changes in the Photopic Negative Response Following Intraocular Pressure Lowering in Glaucoma
Hui F; Hadoux X
Investigative Ophthalmology and Visual Science
2020; 61: 16
90545
Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: A crossover randomized clinical trial
Williams PA
Clinical and Experimental Ophthalmology
2020; 48: 903-914
90237
Short-Term Changes in the Photopic Negative Response Following Intraocular Pressure Lowering in Glaucoma
Soares B
Investigative Ophthalmology and Visual Science
2020; 61: 16
90545
Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: A crossover randomized clinical trial
McGuinness MB
Clinical and Experimental Ophthalmology
2020; 48: 903-914
90237
Short-Term Changes in the Photopic Negative Response Following Intraocular Pressure Lowering in Glaucoma
Jamieson M
Investigative Ophthalmology and Visual Science
2020; 61: 16
90545
Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: A crossover randomized clinical trial
Hadoux X
Clinical and Experimental Ophthalmology
2020; 48: 903-914
90237
Short-Term Changes in the Photopic Negative Response Following Intraocular Pressure Lowering in Glaucoma
van Wijngaarden P
Investigative Ophthalmology and Visual Science
2020; 61: 16
90545
Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: A crossover randomized clinical trial
Casson RJ
Clinical and Experimental Ophthalmology
2020; 48: 903-914
90237
Short-Term Changes in the Photopic Negative Response Following Intraocular Pressure Lowering in Glaucoma
Coote M
Investigative Ophthalmology and Visual Science
2020; 61: 16
90545
Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: A crossover randomized clinical trial
Coote M; Trounce IA
Clinical and Experimental Ophthalmology
2020; 48: 903-914
90237
Short-Term Changes in the Photopic Negative Response Following Intraocular Pressure Lowering in Glaucoma
Crowston JG
Investigative Ophthalmology and Visual Science
2020; 61: 16
90545
Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: A crossover randomized clinical trial
Martin KR; van Wijngaarden P; Crowston JG
Clinical and Experimental Ophthalmology
2020; 48: 903-914
Issue
21-3
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept